Pharma

Zydus Cadila Signs Pact With Gilead To Make Remdesivir

Zydus Cadila Signs Pact With Gilead To Make Remdesivir

Reuters | Friday June 12, 2020

Antiviral drug remdesivir was the first treatment to show improvement in COVID-19 trials.

COVID-19 Crisis: Sun Pharma Testing Plant-Based Drug As Potential Treatment

COVID-19 Crisis: Sun Pharma Testing Plant-Based Drug As Potential Treatment

Reuters | Friday June 05, 2020, Bengaluru

Drug makers around the world are rushing to develop a treatment or vaccine for the fast-spreading novel coronavirus that has killed over 3,90,000 people and ravaged financial markets.

Union Minister Piyush Goyal Meets Pharma Bosses, Announces Divestment

Union Minister Piyush Goyal Meets Pharma Bosses, Announces Divestment

Reported by Sunil Prabhu, Edited by Abhik Deb | Sunday May 31, 2020

The minister said that India has been recognised as the Pharmacy of the World during the COVID-19 crisis

Sun Pharma To Test Pancreatitis Drug In COVID-19 Patients

Sun Pharma To Test Pancreatitis Drug In COVID-19 Patients

Reuters | Friday May 29, 2020

The company joins other drugmakers Glenmark and Strides Pharma Science that are conducting trials in India for potential drugs for COVID-19.

In Virus Crisis, Drug And Consumer Stocks Soar In India

In Virus Crisis, Drug And Consumer Stocks Soar In India

Abhishek Vishnoi, Ronojoy Mazumdar and Ishika Mookerjee, Bloomberg | Friday May 22, 2020

The stockpiling of medicine in a country of 1.3 billion people and the rising focus on affordable health care globally will boost the shares of the nations pharmaceutical companies.

Strides Pharma To Conduct Trials In India For Potential COVID-19 Drug

Strides Pharma To Conduct Trials In India For Potential COVID-19 Drug

Reuters | Thursday May 21, 2020, Bengaluru

Bengaluru-based Strides Pharma Science has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country.

Serum Institute To Make Crores Of Potential Coronavirus Vaccine Doses

Serum Institute To Make Crores Of Potential Coronavirus Vaccine Doses

Reuters | Thursday April 30, 2020

Serum, the world's largest maker of vaccines by volume, is mass-producing the vaccine candidate developed by the University of Oxford.

Glenmark To Conduct Clinical Trials For Potential COVID-19 Drug; Shares Surge

Glenmark To Conduct Clinical Trials For Potential COVID-19 Drug; Shares Surge

Edited by Abhishek Vasudev (with inputs from Reuters) | Thursday April 30, 2020

Glemark said the approval made it the first pharmaceutical company in India to be given the go-ahead to start trials on COVID-19 patients.

Glenmark Pharma To Conduct Trials For Potential COVID-19 Drug, Shares Jump

Glenmark Pharma To Conduct Trials For Potential COVID-19 Drug, Shares Jump

Reuters | Thursday April 30, 2020, Bengaluru

Glenmark Pharmaceuticals, which rose as much as 8.9 per cent to Rs 359, traded up 5.9 per cent at 9:37 am.

Sun Pharma Says Halol Unit Issues Not Likely To Impact Business, Shares Edge Higher

Sun Pharma Says Halol Unit Issues Not Likely To Impact Business, Shares Edge Higher

Edited by Sandeep Singh (with inputs from agencies) | Monday March 30, 2020

Sun Pharma said it continues to manufactureand distribute existing products for the US market.

Government Restricts Export Of Some Pharma Ingredients, Drugs

Government Restricts Export Of Some Pharma Ingredients, Drugs

Reuters | Tuesday March 03, 2020

Indian pharma companies get almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.

Sun Pharma Flags Hypertension Drug Shortage Due To Supply Constraint

Sun Pharma Flags Hypertension Drug Shortage Due To Supply Constraint

Reuters | Monday March 02, 2020

Indian companies are the main supplier of generic drugs to the world and procure almost 70 per centof the active pharmaceutical ingredients (APIs) for their medicines from China. The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies.

Cipla Shares Fall 6% After US Regulator's Warning Letter On Goa Facility

Cipla Shares Fall 6% After US Regulator's Warning Letter On Goa Facility

Edited by Sandeep Singh | Wednesday February 26, 2020

Cipla Share Price: Cipla said it will work closely with the US Food and Drug Administration (FDA) to comprehensively address all the observations.

Generic Drugmakers May Face Supply Shortages From China If Coronavirus Drags On

Generic Drugmakers May Face Supply Shortages From China If Coronavirus Drags On

Reuters | Friday February 14, 2020

An important supplier of generic drugs to the world, Indian companies procure almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.

Industry Body Calls For Reduction In GST On Active Pharmaceutical Ingredients

Industry Body Calls For Reduction In GST On Active Pharmaceutical Ingredients

Edited by Abhishek | Thursday January 16, 2020

Pharma formulations attract GST of 12 per cent whereas inputs active pharmaceutical ingredients (API) have GST of 18 per cent which has led to accumulation of Input tax Credit.

12345...6